O-(piperidinyl) ethyl derivative of Cleistanone as well as preparation method and application thereof

A technology of ethyl derivatives and cleistanone, which is applied in the field of preparation of O-ethyl derivatives of cleistanone to achieve good anti-heart failure effect
CN104098644AInactive Publication Date: 2014-10-15NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY

Patent Information

Authority / Receiving Office
CN ยท China
Current Assignee / Owner
NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
Publication Date
2014-10-15
Estimated Expiration
Not applicable ยท inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the field of organic synthesis and medicinal chemistry, particularly to an O-(piperidinyl) ethyl derivative of Cleistanone as well as a preparation method for the O-(piperidinyl) ethyl derivative of the Cleistanone and the application of the O-(piperidinyl) ethyl derivative of the Cleistanone in preparing drugs for resisting heart failure. The invention synthesizes a novel O-(piperidinyl) ethyl derivative of the Cleistanone and discloses the preparation method thereof. Pharmacological experiment results show that the O-(piperidinyl) ethyl derivative of the Cleistanone has the function of resisting heart failure and has the value of developing drugs for resisting heart failure.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the fields of organic synthesis and medicinal chemistry, in particular to O-(piperidinyl)ethyl derivatives of cleistanone, a preparation method and uses thereof. Background technique

[0002] Heart failure (HF) refers to a pathophysiological state in which abnormal cardiac function causes the pumping volume of the heart to fail to meet the needs of tissue metabolism. The etiology is cardiac overload, limited relaxation of the myocardium itself, and initial myocardial damage caused by any reason; while infection, anemia, pregnancy, childbirth, cardiac rhythm disorder, pulmonary embolism, hyperthyroidism, diabetes, and heart inhibitors induce aggravated HF. Pathogenesis In the past, it was believed that the mechanism of HF development was abnormal hemodynamics; in the late 1980s, it was recognized that the activation of neuroendocrine hormones played an important role (activation of sympathetic โ†‘ NE โ†‘ RAS โ†‘ etc.); after the 1990s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More